Last update:

Diabetes news

Diabetes

New insights into diabetes-related vision problems to inform treatment and prevention

A study published in Proceedings of the National Academy of Sciences details the role of the protein Pentraxin 3 (PTX3) in diabetic retinopathy, a leading cause of blindness and visual impairment.

Diabetes

A new injectable shows promise to prevent and treat hypoglycemia

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which can lead to dizziness, ...

Diabetes

Novel regulator of glucose transport in adipose tissue discovered

The role of the adapter protein PICALM (phosphatidylinositol-binding clathrin assembly protein) in the development of Alzheimer's disease is well documented. Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke ...

Diabetes

The hidden health risks of styrene and ethylbenzene exposure

Type 2 diabetes mellitus (T2DM) is a critical public health issue, with its prevalence expected to rise sharply worldwide. Recent evidence points to environmental pollution, specifically exposure to hazardous chemicals like ...

Diseases, Conditions, Syndromes

Study reveals how COVID-19 infection can cause or worsen diabetes

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens complications in people ...

Health

Air pollution contributes significantly to diabetes globally

New research links outdoor air pollution—even at levels deemed safe—to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) ...

Diabetes

FDA approves continuous glucose monitoring system

(HealthDay)—The Eversense Continuous Glucose Monitoring (CGM) system, which has a fully implantable sensor to detect glucose, has been approved by the U.S. Food and Drug Administration for use in people age 18 years and ...

Diabetes

Intervention programs prevent diabetes distress in teens

Intervention programs that start before psychological symptoms develop can prevent diabetes distress (DD) in teens with type 1 diabetes, according to a study published in the June issue of Diabetes Care.

Diabetes

Insulin glargine 300 safe, effective in seniors with T2DM

(HealthDay)—For older adults, insulin glargine 300 units/mL (Gla-300) is safe and as effective as Gla-100, with a similarly low or lower risk of symptomatic hypoglycemia, according to a study published online June 12 in ...

Diabetes

Aspirin use doesn't cut cancer incidence in older T2DM patients

(HealthDay)—For Japanese patients with type 2 diabetes, low-dose aspirin is not associated with reduced cancer incidence, except in those younger than 65 years, according to a study published online June 16 in Diabetes ...

Diabetes

Possible link found between diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide—the most common white pigment in everyday products ranging from paint to candies—were found in ...

Diabetes

HbA1c targets should be personalized in type 2 diabetes

(HealthDay)—For non-pregnant adults with type 2 diabetes, hemoglobin A1c (HbA1c) targets should be personalized, according to a Clinical Guidelines Synopsis published in the June 19 issue of the Journal of the American ...

Diabetes

Stigma adds to burden of type 1 diabetes

(HealthDay)—Michael Wright was just 16 when he was diagnosed with type 1 diabetes, and although his friends supported him, he always felt different.

Diabetes

A mobile application for diabetes

Diabetes is a chronic disorder affecting millions of individuals worldwide. European scientists plan to improve patients' lifelong adherence to treatment through a mobile application.

Diabetes

Elevated NT-proBNP found to up cardiovascular risk in T2DM

(HealthDay)—Elevated baseline N-terminal B-type natriuretic peptide (NT-proBNP) is independently associated with development of major cardiovascular (CV) events, in particular hospitalization for heart failure, according ...